GDS Wealth Management Acquires 4,056 Shares of IQVIA Holdings Inc. (NYSE:IQV)

GDS Wealth Management lifted its holdings in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 8.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,893 shares of the medical research company's stock after acquiring an additional 4,056 shares during the quarter. GDS Wealth Management's holdings in IQVIA were worth $13,008,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Empowered Funds LLC grew its holdings in shares of IQVIA by 35.5% during the first quarter. Empowered Funds LLC now owns 2,512 shares of the medical research company's stock worth $635,000 after purchasing an additional 658 shares during the last quarter. Sei Investments Co. raised its stake in shares of IQVIA by 4.8% in the first quarter. Sei Investments Co. now owns 57,887 shares of the medical research company's stock worth $14,638,000 after acquiring an additional 2,638 shares during the last quarter. NorthRock Partners LLC acquired a new position in shares of IQVIA during the first quarter worth approximately $233,000. Meeder Advisory Services Inc. grew its stake in shares of IQVIA by 5.7% during the first quarter. Meeder Advisory Services Inc. now owns 3,148 shares of the medical research company's stock valued at $796,000 after purchasing an additional 169 shares during the last quarter. Finally, Inspire Advisors LLC raised its position in IQVIA by 11.8% in the 1st quarter. Inspire Advisors LLC now owns 2,200 shares of the medical research company's stock worth $556,000 after purchasing an additional 233 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now owns 19,536 shares of the company's stock, valued at $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.60% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on IQV shares. Argus raised IQVIA to a "strong-buy" rating in a research note on Wednesday, July 31st. Redburn Atlantic started coverage on IQVIA in a report on Monday, October 14th. They set a "buy" rating and a $276.00 price objective for the company. UBS Group raised their target price on shares of IQVIA from $295.00 to $300.00 and gave the company a "buy" rating in a research note on Tuesday, July 23rd. StockNews.com downgraded shares of IQVIA from a "buy" rating to a "hold" rating in a research note on Friday. Finally, Jefferies Financial Group cut shares of IQVIA from a "buy" rating to a "hold" rating and reduced their price objective for the company from $266.00 to $242.00 in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $259.13.

IQVIA Stock Down 0.7 %

Shares of NYSE IQV traded down $1.52 during mid-day trading on Monday, reaching $217.71. 1,065,812 shares of the company's stock were exchanged, compared to its average volume of 1,101,192. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The business has a fifty day simple moving average of $231.00 and a 200 day simple moving average of $229.16. IQVIA Holdings Inc. has a twelve month low of $191.45 and a twelve month high of $261.73. The firm has a market capitalization of $39.51 billion, a price-to-earnings ratio of 28.77, a PEG ratio of 2.25 and a beta of 1.51.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.